What is it about?

The new European In Vitro Diagnostic Regulation restricts the use of lab-developed tests after May 2022. Compliance for LDTs will require a major investment of time and effort. Clarification is needed on the degrees of freedom laboratories have to use LDTs to improve patient care.

Featured Image

Read the Original

This page is a summary of: The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care, Clinical Chemistry and Laboratory Medicine (CCLM), July 2020, De Gruyter,
DOI: 10.1515/cclm-2020-0804.
You can read the full text:

Read

Contributors

The following have contributed to this page